Tony Hagen is senior managing editor for The Center for Biosimilars®.
Anurag S. Rathore, PhD, wins a grant and the use of scientific instruments from Agilent to further his investigation.
Anurag S. Rathore, PhD, has become the first from India to receive the Agilent Technologies Thought Leader Award. Rathore was recognized for his contributions to biopharmaceutical research and his efforts to advance the molecular characterization of biosimilars.
The characterization of biosimilars is a process that helps determine the bioequivalence of these products to reference, or original, drugs. Characterization also establishes the nature and extent of differences between biosimilar candidates and their reference products and whether these are clinically meaningful.
As recipient of the award, Rathore receives Agilent equipment and a grant to support his research. He joins 47 others who have received the Agilent awards previously.
Agilent, a 1999 spinoff from Hewlett-Packard, is a Santa Clara, California–based analytical instrumentation developer and manufacturer.
Rathore is a professor and scientist at the Indian Institute of Technology (IIT) Delhi. He earned his PhD from Yale University and currently works in the Department of Chemical Engineering at ITT Delhi. He is a member of the Parenteral Drug Association and American Chemical Society and is the author of more than 400 publications and presentations. He is also editor-in-chief of Preparative Biochemistry and Biotechnology. Information about his publications can be accessed by clicking here.
Rathore recently spoke with The Center for Biosimilars® about a study he conducted on reasons that applications for biosimilar regulatory approval fail.